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Objective: To assess the utility of the neutrophil-to-lymphocyte ratio (NLR) in predict-
ing outcome in canine pneumonia compared with routine hematological parameters
and systemic inflammatory response syndrome (SIRS) scores.
Design:Retrospective study.
Setting:University teaching hospital.
Animals: Forty-nine client-owned dogs.
Interventions:None
Measurements and Main Results: Medical records were reviewed to identify dogs
with a diagnosis of pneumonia from July 2011 to December 2016. Signalment, clin-
ical findings, laboratory characteristics, and outcome were recorded. Inclusion crite-
ria were a clinical and radiographic diagnosis of pneumonia, plus reference laboratory
hematology at diagnosis. Cases that received steroids were excluded. Euthanized dogs
were only included in statistical analysis if euthanized solely due to pneumonia sever-
ity. The NLR, total WBC count, neutrophil count, lymphocyte count, band neutrophil
percent of total WBC count (%-bands), and percentage of cases diagnosed with SIRS
were compared between survivors and nonsurvivors. Receiver operating characteris-
tic curveswere generated to identify optimal sensitivity and specificity cutoffs for non-
survival to discharge.
Two hundred records were retrieved; 49 cases fulfilled the inclusion criteria. Of these,
33 (67%) survived to discharge. The NLR did not differ significantly between the sur-
vivors and nonsurvivors, nor did total WBC count or neutrophil count. Survivors had
a significantly lower %-bands than nonsurvivors (P < 0.001) and higher lymphocyte
count (P= 0.004). Themortality rate did not differ significantly between dogswith and
Abbreviations: %-bands, band neutrophil percent of totalWBC count; APPLE score, acute patient physiologic and laboratory evaluation score; AUC, area under the curve; CAP,
community-acquired pneumonia; CRP, C-reactive protein; DLS, degenerative left shift; NLR, neutrophil-to-lymphocyte ratio; ROC, receiver operating characteristic; SIRS, systemic inflammatory
response syndrome
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without SIRS. Receiver operating characteristic analysis identified a %-bands cutoff of
2.5% or higher had an 83% sensitivity and 79% specificity for nonsurvival.
Conclusions: Unlike in human medicine, neither NLR nor SIRS scores predicted out-
come in this cohort of dogs with pneumonia. However, survivors had a lower %-bands
and higher lymphocyte count than nonsurvivors, which may be helpful prognostically
in clinical cases.
KEYWORDS
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1 INTRODUCTION
Pneumonia is a common cause of respiratory disease in dogs and has
a variety of etiologies, including infectious pneumonia and aspiration
pneumonia. In both human and canine medicine, pneumonia can vary
in severity but is a common cause of sepsis and the systemic inflamma-
tory response syndrome (SIRS). Reported mortality rates for pneumo-
nia in veterinary medicine are approximately 20%,1,2 whereas in peo-
ple themortality rate varieswidely, from as low as 1% to as high as 59%
depending on the patient population studied.3,4
In human medicine, there are a number of clinical scoring systems
to stratify patients with pneumonia by mortality risk, including the
British Thoracic Society Score, North American Pneumonia Severity
Index, and the CURB-65 score.3,5,6 Biomarkers such as C-reactive pro-
tein (CRP) also have some prognostic use in various subsets of pneu-
monia patients. Although there are a number of veterinary scoring
systems for predicting prognosis in acute ICU admissions such as the
acute patient physiologic and laboratory evaluation (APPLE) score and
SIRS score, these are diagnosis independent scores.7,8 There are few
studies looking at prognostic indicators in canine pneumonia and no
pneumonia-specific scores. In one study, the number of lung lobes
affected radiographically was significantly higher in nonsurvivors than
survivors, but no other clinicopathological differenceswere reported.1
Although CRP at presentation has some use in differentiating bron-
chopneumonia fromother respiratory diseases,9 in a subsequent study
it had no correlation with duration of hospitalization or other mark-
ers of disease severity; however, its association with survival was not
evaluated.10 In populations of dogs with SIRS resulting from mixed
underlying conditions, CRPwas not prognostic for survival.11,12
In human medicine, there has been recent interest in developing
less expensive and more easily accessible biomarkers to help pre-
dict prognosis in individuals with pneumonia. Studies have shown
the neutrophil-to-lymphocyte ratio (NLR), calculated from the stan-
dard hematological peripheral blood total neutrophil and lympho-
cyte counts, is as good a predictor of severity and outcome as the
Pneumonia Severity Index and CURB-65 scores and a better predic-
tor than some classical biomarkers such as CRP.13,14 In veterinary
medicine, the NLR has diagnostic and prognostic relevance in various
canine tumors.15,16 And although the NLR is not associated with dura-
tion of hospitalization, APPLE scores, or mortality in dogs with septic
peritonitis,17 no studies have evaluated its utility in canine pneumonia.
The aims of this study were to assess whether the NLR is a useful
prognostic marker in canine pneumonia and to compare the prognos-
tic value of theNLRwith other routine hematological parameters, CRP
and SIRS scores.
2 MATERIALS AND METHODS
A retrospective study of canine pneumonia cases between July 2011
and December 2016 was performed by searching the hospital imag-
ing records for the keyword “pneumonia” as a differential diagnosis.
Full case records were then reviewed for suitability. Inclusion criteria
were a final clinical diagnosis of pneumonia made by a combination
of lower respiratory tract signs and radiographic or computed tomog-
raphy changes compatible with pneumonia, plus a CBC and blood
smear examination performed at a reference laboratory, either within
24 hours of admission for newly presenting cases or within 24 hours of
onset of respiratory signs for cases developing pneumoniawhile hospi-
talized. All radiographs and computed tomography images were evalu-
ated by a board-certified radiologist or a resident in an approved train-
ing program under the supervision of a board-certified radiologist. All
total WBC counts were performed on an automated hematology ana-
lyzer* with a WBC differential performed by a board-certified clinical
pathologist. Cases with concurrent conditions such as lymphoma or
leukemia, and any treated with drugs such as steroids or chemother-
apeutic agents that could independently affect differentialWBC, were
excluded. Cases with only a CBC performed on the in-house analyzer
without manual smear examination were excluded for consistency in
measurementmethods.
Routine clinical, hematological, and biochemical data, number and
type of concurrent conditions predisposing to aspiration, final diagno-
sis, plus the outcomemeasures hospitalization time and survival to dis-
charge were collected for all cases. Dogs not admitted to the hospi-
tal and treated as outpatients were allocated a hospitalization time of
0 days. Where dogs were euthanized, records were reviewed to try
to determine the reason for euthanasia. These were divided into the
categories of “severity of pneumonia,” “cost,” “long-term prognosis,”
“not recorded,” or a combinationof those categories. Caseswere classi-
fied asbeingeuthanizeddue to severity of pneumonia alone if thenotes
recorded worsening of tachypnea, dyspnea, respiratory effort, pulse
oximetry readings <90%, or cyanosis, plus recorded recommendation
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of euthanasia by the case clinician, with no other records of concerns
over cost or long-term prognosis. Otherwise, cases were classified as
having a combination of reasons for euthanasia.
SIRS scores at admission were calculated for all cases for which
there were sufficient data available. Dogs were classified as hav-
ing SIRS if they fulfilled 2 or more of the following criteria: body
temperature <38.1◦C or >39.2◦C; heart rate >120/min; respira-
tory rate >20/min; total WBC count <6.0 × 109/L (<6 × 103/µL)
or >16 × 109/L (>16 × 103/µL); and percentage of bands >3% of the
total WBC count, as per the previously reported criteria.8 Descriptive
statistics for total WBC count, total neutrophil count (segmented and
band neutrophils), lymphocyte count, band neutrophil count, total neu-
trophil percent of total WBC count, band neutrophil percent of total
WBC count (%-bands), lymphocyte percent of total WBC count, NLR,
and SIRS score were generated and compared between dogs that did
and did not survive to discharge.Only dogs that either died naturally or
were euthanized solely due to the severity of pneumoniawere included
in the nonsurvivors group.
2.1 Statistical methods
All data were tested for normality using a Shapiro–Wilk test. Non-
parametric data were then compared between groups using a
Mann–Whitney U-test. Receiver operating characteristic (ROC) curve
analysis was used to identify cutoff levels for sensitivity and specificity
for nonsurvival to discharge for those parameters showing a statisti-
cally significant difference between survivors and nonsurvivors. The
proportion of dogs with SIRS was compared between survivors and
nonsurvivors using a chi-squared test. The data were also evaluated
for correlations with hospitalization time in the survivors using Spear-
man’s rank correlation. A P-value < 0.05 was considered statistically
significant. All statistical analyses were performed using commercially
available statistical software.†
3 RESULTS
Two hundred records were retrieved, of which 49 cases fulfilled the
inclusion criteria. The median age was 5 years (range, 2 wk to 13 y).
Six dogs were mixed breeds, and 43 were pure breeds, with 28 dif-
ferent breeds represented. Weimaraners (n = 4) were the most com-
mon pure breed, followed by Pugs and Great Danes (n = 3), then Bor-
der Collies, Boston Terriers, Boxers, Bulldogs, Scottish Terriers, Shih
Tzus, Staffordshire Bull Terriers, and Yorkshire Terriers (all n = 2). The
median hospitalization time for all dogs was 3.5 days, ranging from 0
to 25 days. Of the final diagnoses, 36 of the 49 patients had a diagno-
sis of “aspiration pneumonia,” whereas the remainder were diagnosed
with “pneumonia” or “bronchopneumonia.” Dogs with a final diagno-
sis of aspiration pneumonia had a mortality rate of 36%, compared to
23% for other pneumonia subtypes; this was not significantly different
(P= 0.39).
Thirty-four of the dogs had 1 or more concurrent conditions
reported to predispose to aspiration pneumonia.18 These conditions
included vomiting/regurgitation/esophageal or gastrointestinal dis-
ease (n= 20), laryngeal or pharyngeal disease (n= 5), neurological dis-
ease (n = 7), and brachycephalic obstructive airway syndrome (n = 5).
Thirty-nine dogs had pneumonia present at the time of referral to the
hospital, whereas 10 developed pneumonia while either hospitalized
or under our outpatient treatment. Of these 10, the underlying pre-
dispositions for pneumonia were recent general anesthetic (n = 6),
esophageal dysmotility (n= 2), and neurological disease (n= 2). Of the
6 dogs recently anesthetized, 2 were for brachycephalic obstructive
airway syndrome surgery, 1 for investigation of hyperglobulinemia, 1
for intestinal leiomyoma resection, 1 for insulinoma excision, and 1 for
cervical disk extrusion. One of the dogs with neurological disease had
hypernatremia, and theotherhada cerebellar infarction.Of all dogs, 13
had antibiotic treatment prior to referral, whereas 26 had not. The sur-
vival rate did not differ, however, between newly presenting dogs pre-
treated with antibiotics and those that were not (69% vs. 73%, respec-
tively). Thirty-nine of the dogs had sufficient data recorded for SIRS
scoring. Only 10 dogs had CRP measurements at admission, ranging
from0 to498mg/L (0–498µg/mL), so further statistical analysis ofCRP
values was not performed.
Of the entire groupof 49dogs, 33 (67%) survived to discharge.Of all
the nonsurvivors, 7 died, whereas 9 were euthanized. Of those 9 euth-
anized, 5 could be retrospectively categorized as being euthanized due
to the severity of pneumonia alone, 2 due to the poor long-term prog-
nosis, and 2 due to a combination of the severity of pneumonia and
the long-term prognosis. The 4 dogs euthanized for reasons other than
pneumonia severity alone were excluded from the statistical analysis.
As such, 45 dogs were included in the NLR analysis, including 12 non-
survivors. There was no significant difference between themedian age
of the survivors (84 months, range, 0.5–144) and the nonsurvivors (54
months, range, 12–156) (P= 0.71).
The median hematological parameters for the 45 dogs are shown in
Table 1. TheNLR (median± SD) did not differ significantly between the
survivors (12.6± 14.5, range, 2.4–47.9) and nonsurvivors (23.4± 15.0,
range, 2.4–48) (P= 0.065; Table 1 & Figure 1). There was also no signif-
icant difference between the groups for total WBC count, neutrophil
count, total neutrophil percent of total WBC count, or lymphocyte
percent of total WBC count. Nonsurvivors had a significantly higher
median %-bands (6.0± 9.0) than survivors (1.0± 1.9) (P= 0.0001; Fig-
ure2) and lower lymphocyte count (nonsurvivors0.37±0.65 [×109/L];
survivors 0.93± 1.3 [× 103/µL]) (P= 0.004; Table 1 & Figure 3).
ROC curves were generated for the 2 parameters that showed a
statistically significant association with the risk of death: the lympho-
cyte count and the%-bands (Figure 4). The area under the curve (AUC)
was higher for the%-bands (0.871; upper bound 1.0, lower bound 0.74)
than for the lymphocyte count (0.785; upper bound 0.94, lower bound
0.63); however, pairwise comparison showed this difference was not
statistically significant (P = 0.16). A cutoff of %-bands greater than
1 gave a sensitivity and specificity of 91% and 67%, respectively, for
death before discharge, whereas a cutoff of 2.5 and greater gave a sen-
sitivity of 83%with a specificity of 79%.Anoptimal specificity for death
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TABLE 1 Median hematological parameters for the 45 client-owned canine pneumonia cases included in the statistical analysis and
comparison between survivors and nonsurvivors
All dogs Subgroups
Median Range Survivors Nonsurvivors P-value
n 45 33 12 –
TotalWBC (× 109/L) (× 103/µL) 14.3 1.0–38.6 14.3 (± 9.2) 12.1 (± 9.8) 0.19
Total neutrophil count (× 109/L) (× 103/µL) 12.0 0.5–35.7 12.0 (± 8.4) 11.3 (± 8.4) 0.24
Mature neutrophil count (× 109/L) (× 103/µL) 11.7 0.3–35.7 12.0 (± 8.1) 10.5 (± 7.5) 0.20
Band neutrophil count (× 109/L) (× 103/µL) 0.21 0.00–5.55 0.11 (± 0.46) 0.5 (± 1.50)* 0.007
Lymphocyte count (× 109/L) (× 103/µL) 0.81 0.05–5.73 0.93 (± 1.3) 0.37 (± 0.65)* 0.004
Total neutrophil % of totalWBC (%) 88.5 48–96 87 (± 9.9) 89 (± 13.0) 0.42
Band% of totalWBC (%) 2 0–30 1.0 (± 1.9) 6.0 (± 9.0)* 0.0001
Lymphocyte% of totalWBC (%) 5.5 2–26 7.0 (± 6.6) 4.0 (± 5.0) 0.06
NLR 16.7 2.4–47.9 12.6 (± 14.5) 23.4 (± 15.0) 0.065
SIRS score points 3 0–5 3.0 (± 1.4) 4.0 (± 1.0) 0.21
SIRS positive (% of cases) 86% (31/36) 80% 100% 0.125
Note: Subgroup results median (± SD).
Abbreviation: NLR, neutrophil-to-lymphocyte ratio; SIRS, systemic inflammatory response syndrome.
*Statistically significant difference between survivors and nonsurvivors.
F IGURE 1 Box andwhisker plot comparing
the neutrophil-to-lymphocyte ratio (NLR) for
survivor versus nonsurvivor dogs treated for
pneumonia. The central horizontal lines
indicate themedian value; the upper and lower
lines of the box plot represent the upper and
lower quartiles of the values, respectively. The
vertical lines indicate the 95% and 5% data
range. Circles represent outliers
of 97%was obtained for a cutoff of 6.0 and greater, with a sensitivity of
50% (Table 2).
For the 36 dogs with SIRS scores, the proportion surviving to dis-
charge did not statistically differ between thosewith (n=31) andwith-
out (n = 5) SIRS (68% and 100%, respectively, P = 0.125). Although
there was a higher percentage diagnosed with SIRS among the non-
survivors, this did not reach statistical significance (100% vs. 80%;
P= 0.125) (Table 1). The median number of SIRS criteria points scored
(of a total of 5, those with 2 or more classified as having SIRS) did
not differ between the survivors (3.0 ± 1.4) and the nonsurvivors
(4.0 ± 1.0) (P = 0.21). The NLR was also not significantly differ-
ent between dogs with and without SIRS (17.8 ± 15.6 vs. 8.9 ± 8.4;
P= 0.06).
For the 33 surviving dogs, the hematological and SIRS data were
evaluated for correlation with duration of hospitalization. The NLR,
neutrophil count, lymphocyte count, andnumber of SIRS criteria points
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F IGURE 2 Box andwhisker plot comparing
the number of bands as a percentage of the
totalWBC count (%-bands) for survivor versus
nonsurvivor dogs treated for pneumonia. The
central horizontal lines indicate themedian
value; the upper and lower lines of the box plot
represent the upper and lower quartiles of the
values, respectively. The vertical lines indicate
the 95% and 5% data range. Circles represent
outliers
F IGURE 3 Box andwhisker plot comparing
total lymphocyte count for survivor versus
nonsurvivor dogs treated for pneumonia. The
central horizontal lines indicate themedian
value; the upper and lower lines of the box plot
represent the upper and lower quartiles of the
values, respectively. The vertical lines indicate
the 95% and 5% data range. Circles represent
outliers. Asterisks represent extreme outliers
showed no significant correlation with hospitalization time. The %-
bands showed a weak but statistically significant positive correlation
with hospitalization time (r= 0.38, P= 0.03).
4 DISCUSSION
Unlike in humanmedicine,13 theNLRwas not prognostic for survival in
this cohort of canine pneumonia patients. Neutrophilia and lymphope-
nia are part of the innate immune response to systemic inflamma-
tion, regardless of initiating cause. Lymphopenia is caused by increased
apoptosis and margination of lymphocytes within organs of the retic-
uloendothelial system. Neutrophilia results from release of mature
neutrophils from the bone marrow storage pool alongside increased
neutrophil productiondue to cytokine stimulationof themarrow.More
marked inflammation can lead to a left shift, where neutrophil precur-
sors including bands are released from the marrow due to extreme
demand. In severe infections, this can progress to a neutropenia due
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TABLE 2 ROC curve data
Parameter Cutoff Sensitivity Specificity
Band neutrophil percent of totalWBC count >1.0 91% 67%
Band neutrophil percent of totalWBC count >2.5 83% 79%
Band neutrophil percent of totalWBC count >6.0 50% 97%
Lymphocyte count (× 109/L) (× 103/µL) <0.89 92% 54%
Lymphocyte count (× 109/L) (× 103/µL) <0.74 75% 70%
Lymphocyte count (× 109/L) (× 103/µL) <0.28 50% 94%
Note: Sensitivity and specificity for nonsurvival for client-owned dogs with pneumonia for the band neutrophil percent of total WBC count at levels above 3
selected cutoffs, and for nonsurvival at levels below 3 selected cutoffs for total lymphocyte count based on ROC curve analysis.
F IGURE 4 ROC curves for band neutrophil percent of totalWBC
count (%-bands) and total lymphocyte count as predictors of
nonsurvival for dogs treated for pneumonia. The area under the curve
(AUC) for the%-bands is 0.871 and for the lymphocyte count is 0.785.
These AUC values indicate good diagnostic accuracy in discriminating
for survival status
to a combination of neutrophil sequestration in infected tissues and
exhaustion of themarrow neutrophil reserve.
Some patients can also show a degenerative left shift (DLS), defined
as when the number of immature band neutrophils present in the cir-
culation exceeds the number of mature neutrophils. The presence of a
DLS is associated with an increased risk of mortality in canine patients
with a variety of disease processes. In a retrospective study of dogs
with a DLS at presentation to a veterinary teaching hospital, pneu-
monia was the most common underlying disease, diagnosed in 19% of
cases.Notably, however,when the significanceof aDLSwasanalyzed in
individual diseases, there was no difference in survival between pneu-
monia patients with and without a DLS.19 In the current study, no dogs
showed a DLS; however, there was a significantly higher %-bands in
the nonsurvivors than in the survivors. Based on ROC curve analysis,
the %-bands also showed a good prognostic value for survival (AUC =
0.87). A%-bands cutoff of 2.5%or greater had 83% sensitivity and 79%
specificity for nonsurvival to discharge. Although in the DLS study, the
severity of the left shiftwas assessedusing the ratio ofmature to imma-
ture neutrophils,19 unlike in the current study, this ratio does not take
into account the total number ofWBC, sowhether a similar association
existed between increasing proportion of bands and survival to that
found here is unknown. Equally, given involvement of a greater number
of lung lobes is associatedwith worse prognosis in canine pneumonia,1
it is possible that respiratory compromise from impaired gas exchange
leads to death in some dogswith pneumonia beforemarrowneutrophil
exhaustion is reached.
A recent prospective study compared various WBC parameters
with some of the newer acute phase biomarkers in human community-
acquired pneumonia (CAP) patients. They found both a higher NLR in
patients dying within 30 days compared to survivors, and a higher neu-
trophil count percentage and lower lymphocyte count percentage, but
no statistical difference in the absolute neutrophil or absolute lympho-
cyte counts between the groups.20 Similar to the current study’s find-
ing of the %-bands having the higher ROC AUC, however, the human
CAP study found the neutrophil count percentage had a higher ROC
AUC than the NLR (0.87 vs. 0.79), and in multivariate analysis only the
admission neutrophil count percentage retained statistical significance
for mortality.20 They did not report the percentage of bands, however,
so whether this parameter may be similarly significant in people, as in
the canine population in the current study, is unknown.20 Overall, it
is possible that differences in WBC kinetics between people and dogs
contributed to this differing significance of absolute cell counts com-
pared to count percentages.
Reasons for the difference in the NLR’s significance between peo-
ple and dogs with pneumonia are likely multifactorial but may in part
be due to the option of euthanasia in veterinary patients. As with all
veterinary studies investigating predictors of survival, euthanasia of
patients due to costs, perceived poor prognosis, or other owner- or
case-specific factors is likely to have a significant confounding effect. In
the current study, attempts were made to address this by only includ-
ing cases where euthanasia was recommended due to the severity of
the pneumonia and an actively deteriorating clinical picture such that
death was considered inevitable. However, it is important to note that
this retrospective classification of reasons for euthanasia has signifi-
cant limitations, in that only information recorded in the case records
can be evaluated, and subtle impacts of factors such as cost may
have played a role in either the veterinarian’s or owners’ decision to
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euthanize a patient, even if they were not verbalized or formally
recorded in the records. Although the difference in the median NLR
between survivors and nonsurvivors was not statistically significant, it
was similar in magnitude to that seen in larger human studies evaluat-
ing the NLR.13,20 As such, it is possible that inclusion of a larger num-
ber of dogsmay have detected a significant difference, and the present
study has not because of a type II error. Future prospective studies that
are larger in size and that exclude all euthanized patients may be war-
ranted to further assess the utility of the NLR.
Differences in pneumonia type may also play a role in the different
significance of the NLR between human and canine patients. Although
in human studies the reported proportion of patients with CAP with
the subtype of aspiration pneumonia varies between 7% and 24%,4,21
in the current study, 73%of dogs had a final recorded diagnosis of aspi-
ration pneumonia. Despite many instances of aspiration involving true
bacterial colonization of the lower respiratory tract, either from aspi-
ration of large particulate gastric contents or secondary opportunistic
infection, a proportion of cases are better described as a pneumonitis
due to chemical injury and sterile inflammation within the airways.22
As many pneumonia patients are insufficiently stable for anesthesia
and sampling of the lower airways for bacterial isolation, combined
with the low positive culture rates seen in true bacterial pneumonia,
it is difficult to achieve a definitive differentiation between pneumoni-
tis and bacterial pneumonia in clinical cases, both in human and vet-
erinary medicine.1,4,23,24 In human medicine, although the NLR has a
good positive predictive value for bacteremia in patients with a variety
of conditions presenting for emergency care,25 routine WBC counts
have not been shown to differ between ventilated patients with con-
firmed pneumonitis and those with bacterial pneumonia.26 Whether
the NLRmay differ between canine patients with bacteremia or sepsis
compared to those with nonseptic inflammation is unknown. A recent
meta-analysis of mortality risk in human aspiration patients compared
to other CAP patients found that those with a risk factor for aspira-
tion and, therefore, presumed aspiration pneumonia, had a more than
3-fold increased risk of in-hospital and 30-day mortality.4 In the cur-
rent study, dogs with a final diagnosis of aspiration pneumonia had a
slightly higher mortality rate than those with other pneumonia sub-
types, although this did not reach statistical significance. Thus, it is pos-
sible that relatively high mortality rates in the current study due to
overrepresentation of aspiration cases affected the prognostic use of
the NLR. Future investigation into whether there is a survival differ-
ence between canine pneumonia patients with known aspiration com-
pared to thosewith bacterial pneumonia secondary to other etiologies,
and whether the NLR has any prognostic use in the latter population,
would be useful.
There are several limitations to the current study. The study popu-
lation included dogs referred for known respiratory disease, including
dogswith acute untreated pneumonia, treated butworsening pneumo-
nia, and stable or improving pneumonia requiring ongoing care, plus
dogs that newly developed pneumonia while hospitalized for other
conditions. Although 33% of dogs received antibiotics prior to refer-
ral, due to the retrospective nature of the study, the specifics of treat-
ment duration prior to referral were not available in the majority of
cases. As a result, there is likely variability in the timing of the CBC
fromwhich the NLR was calculated in relation to onset of clinical signs
and, therefore, our findings may not be directly applicable to acute
untreated pneumonia patients presenting to primary care practice.
Future prospective studies in which theNLR is calculated at serial time
points or only in untreated patients would help clarify its prognostic
utility.
A further limitation of the current study being performed in a
referral practice is that this may have introduced a selection bias for
sicker patients, because a major reason for referral of patients with
pneumonia to specialty hospitals is the need for 24-hour ICU care.
Thus, further investigation of the predictive value of theNLR and other
hematological variables in a general practice population of dogs with
pneumoniamay bewarranted. An inclusion criterionwas a hematology
and smear exam performed at the reference laboratory, partly for
consistency inmeasurementmethods, and partly because the in-house
laboratory point-of-care analyzer cannot count band neutrophils.
The advantage to the NLR is that it is easy to calculate based on
results from automated hematology cell counters that are available to
most veterinarians in general and emergency out-of-hours practice.
Although the %-bands had prognostic value for canine pneumonia
patients, calculating thismeasure requires amanual blood smear exam,
making it more time-consuming to determine than the NLR. Finally,
although it was hoped to additionally evaluate the utility of baseline
CRP as a prognostic indicator in this population, only 10 dogs fulfilling
the inclusion criteria had CRP measured at presentation. As this small
number of eligible dogs would be underpowered to detect a significant
difference, CRPwas excluded from the statistical analyses.
Failure to find a significant difference in survival between dogs with
and without SIRS at presentation may have been due to a type II error
from the low number of dogs not fulfilling the SIRS criteria. This limi-
tation is also likely a reflection of the current study being performed
at a referral hospital and arguably representing a sicker population of
dogs affected by pneumonia. Future studies including more dogs over-
all and less severely affected dogs from a primary care population to
reflect a wider spectrum of disease severity might better evaluate the
prognostic implications of SIRS at diagnosis. Additionally, SIRS is a very
nonspecificmarker of illness severity,merely reflecting the presence or
absence of systemic inflammation. As such, it is not designed to differ-
entiate betweenmoderate andhigh severities of systemic illness. Itwas
not possible to evaluate alternative disease severity scoring systems,
such as APPLE scores, as additional data such as lactatemeasurements
were not available for most cases in the current study.
To the authors’ knowledge, there are no previous studies evalu-
ating the prognostic value of WBC percentages in canine pneumo-
nia. The current study found that although the NLR was not useful
prognostically, the number of band neutrophils as a percentage of the
total WBC count (%-bands) was significantly higher in nonsurvivors
than survivors and showed a weak correlation with longer duration of
hospitalization in survivors. Although a %-bands of greater than 2.5%
had a specificity of 79% for death in hospital, further studies evaluat-
ing this in a larger population of dogs presenting to both referral and
primary care practiceswould be of interest. Additionally, larger studies
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including additional clinicopathological variables such as biochemical
data and CRP may allow development of a better performing multipa-
rameter disease-specific scoring system for canine pneumonia, similar
to those used in humanmedicine.
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